Description
CVS Health Corporation: Will The Increasing Margin in Medicare Advantage Last?
In the Q1 2024 earnings, CVS Health is experiencing both positive and negative impacts on its business structure. The company reported lower-than-expected earnings per share of $1.31 due to significant utilization pressures in the Medicare Advantage, largely impacting its Health Care Benefits segment. Due to these results and revised expectations for the rest of 2024, CVS has lowered full-year guidance for adjusted EPS to at least $7.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
